- Trials with a EudraCT protocol (65)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
65 result(s) found for: Microperimetry.
Displaying page 1 of 4.
EudraCT Number: 2008-008200-40 | Sponsor Protocol Number: VGFT-OD-0706 | Start Date*: 2009-05-20 |
Sponsor Name:Regeneron Pharmaceuticals, Inc | ||
Full Title: A Double-Masked, Randomized, Controlled Study of the Safety, Tolerability and Biological Effect of Repeated Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Macular Edema (DME) | ||
Medical condition: Diabetic Macular Edema (DME) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003852-60 | Sponsor Protocol Number: NSR-RPGR-01 | Start Date*: 2017-01-09 | |||||||||||
Sponsor Name:NightstaRx Limited | |||||||||||||
Full Title: A Dose Escalation (Phase 1), and Dose Expansion (Phase 2/3) Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using an Adeno-Associated Viral Vector (AAV8) Encoding Retinitis... | |||||||||||||
Medical condition: X-Linked retinitis pigmentosa (XLRP) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001435-52 | Sponsor Protocol Number: APL2-304 | Start Date*: 2018-12-10 | |||||||||||
Sponsor Name:Apellis Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal Pegcetacoplan Therapy with Sham Injections in Patients with Geographic A... | |||||||||||||
Medical condition: Geographic Atrophy Secondary to Age-Related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) NL (Completed) ES (Ongoing) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001678-25 | Sponsor Protocol Number: 138/06 | Start Date*: 2006-02-16 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Macular structure and function after intravitreal injection of bevacizumab for vascular retinopathy a interventional study. | |||||||||||||
Medical condition: vascular retinopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021777-37 | Sponsor Protocol Number: Lucentis-LucERG | Start Date*: 2010-09-27 | |||||||||||
Sponsor Name:Universitätsklinikum Schleswig-Holstein (UK-SH) | |||||||||||||
Full Title: "A prospective, non-randomized, mono-center, cohort study to evaluate the short- and long-term effects of 0.5mg intraocular Ranibizumab (Lucentis) injections on retinal function in patients with we... | |||||||||||||
Medical condition: Retinal function in patients with wet age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002931-32 | Sponsor Protocol Number: APL2-GA-305 | Start Date*: 2021-09-17 | |||||||||||
Sponsor Name:Apellis Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3 open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan in subjects with geographic atrophy secondary to age-related macular degeneration | |||||||||||||
Medical condition: Geographic Atrophy Secondary to Age-Related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) DE (Trial now transitioned) FR (Ongoing) CZ (Ongoing) PL (Trial now transitioned) ES (Ongoing) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003288-21 | Sponsor Protocol Number: EURIVAT2 | Start Date*: 2005-09-28 |
Sponsor Name:Dept. of Ophthalmology, Medical University of Vienna | ||
Full Title: INTRAOCULAR BEVACIZUMAB (AVASTIN™) FOR CENTRAL AND BRANCH RETINAL VEIN OCCLUSION STUDY | ||
Medical condition: CENTRAL AND BRANCH RETINAL VEIN OCCLUSION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006871-19 | Sponsor Protocol Number: 121206 | Start Date*: 2007-08-03 |
Sponsor Name:Universitätsklinik für Augenheilkunde und Optometrie, MUW | ||
Full Title: | ||
Medical condition: Macular changes after vitroretinal surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001869-41 | Sponsor Protocol Number: OKHN1005 | Start Date*: 2011-08-24 | ||||||||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: An exploratory study of ranibizumab (Lucentis) for treatment of uveitic patients with refractory cystoid macular oedema. 'The LIMO study' | ||||||||||||||||||
Medical condition: Uveitic Macular Oedema | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-002826-31 | Sponsor Protocol Number: V1 | Start Date*: 2007-11-09 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Response of retinal vessels to anti vascular endothelial growth factor (VEGF) treatment in patients with branch retinal vein occlusion (BRVO) | ||
Medical condition: Cystoid macular oedema due to branch retinal vein occlusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004555-36 | Sponsor Protocol Number: PLACE | Start Date*: 2014-07-28 | |||||||||||
Sponsor Name:Centre Hospitalier Intercommunal de Créteil | |||||||||||||
Full Title: A prospective randomized controlled multicentre trial comparing half-dose photodynamic therapy (PDT) with high-density subthreshold micropulse laser treatment in patients with chronic central serou... | |||||||||||||
Medical condition: Chronic central serous chorioretinopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000106-35 | Sponsor Protocol Number: GX29185 | Start Date*: 2015-02-02 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDAR... | |||||||||||||
Medical condition: Geographic atrophy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) AT (Completed) DK (Prematurely Ended) GB (Prematurely Ended) SE (Completed) NL (Prematurely Ended) ES (Completed) BE (Prematurely Ended) PT (Prematurely Ended) SK (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003320-36 | Sponsor Protocol Number: 190342-038 | Start Date*: 2015-03-02 | |||||||||||
Sponsor Name:Allergan Limited | |||||||||||||
Full Title: Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON Study) | |||||||||||||
Medical condition: Geographic Atrophy Secondary to Age-related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000107-27 | Sponsor Protocol Number: GX29176 | Start Date*: 2015-02-02 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDAR... | |||||||||||||
Medical condition: Geographic atrophy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) AT (Completed) DK (Prematurely Ended) GB (Prematurely Ended) PL (Prematurely Ended) NL (Prematurely Ended) SK (Completed) ES (Completed) BE (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004783-35 | Sponsor Protocol Number: OPH2005 | Start Date*: 2018-07-10 | |||||||||||
Sponsor Name:IVERIC bio | |||||||||||||
Full Title: A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects with Autosomal Recessive Stargardt Disease | |||||||||||||
Medical condition: Autosomal Recessive Stargardt Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) GB (GB - no longer in EU/EEA) HU (Completed) ES (Ongoing) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023111-34 | Sponsor Protocol Number: SG1/001/10 | Start Date*: 2011-07-18 |
Sponsor Name:Oxford BioMedica (UK) Ltd | ||
Full Title: A Phase I/IIa Dose Escalation Safety Study of Subretinally Injected StarGen, Administered to Patients with Stargardt's Macular Degeneration. | ||
Medical condition: Stargardt Macular Dystrophy, also known as fundus flavimaculatus or Stargardt disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) NL (Not Authorised) IT (Prematurely Ended) Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2012-004758-27 | Sponsor Protocol Number: V1 | Start Date*: 2013-01-30 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Augenheilkunde | ||
Full Title: fMRI analysis of the visual cortex in neovascular age-related macular degeneration | ||
Medical condition: 20 patients with neovascular age-related macular degeneration will be examined before and after 3 monthly administered intravitreal ranibizumab injections according to the label with 7 tesla magnet... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004769-15 | Sponsor Protocol Number: V1.2 | Start Date*: 2013-12-13 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Augenheilkunde | ||
Full Title: fMRI analysis of the visual cortex in neovascular Age-related Macular Degeneration | ||
Medical condition: 20 patients with neovascular age-related macular degeneration will be examined before and after 3 monthly administered intravitreal ranibizumab injections according to the label with 3 tesla magnet... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-015516-18 | Sponsor Protocol Number: 001 | Start Date*: 2010-08-06 |
Sponsor Name:Univ.-Klinik für Augenheilkunde und Optometrie, Medizinische Universität Wien | ||
Full Title: Microstructural morphological changes of the macula after intravitreal microplasmin for non-surgical treatment of vitreomacular traction syndrome | ||
Medical condition: Vitreomacular traction syndrome (VMTS) is a distinct clinical entity characterized by an incomplete separation of the posterior vitreous surface from the retina with persistent posterior hyaloid ad... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-008259-41 | Sponsor Protocol Number: OZR-2008-20 | Start Date*: 2009-03-30 |
Sponsor Name:Rotterdam Eye Hospital | ||
Full Title: Anti-VEGF (bevacizumab/ranibizumab) versus RPE-choroid graft in the treatment of 1) non-responders to 3 intravitreal anti-VEGF injections, or 2) patients with AMD and pigment epithelium rip, or 3) ... | ||
Medical condition: Age related macular degeneration and either of the following conditions: 1) not responding to 3 intravitreal anti-VEGF injections, or 2) pigment epithelium rip, or 3) massive haemorrhage. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
